Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer

By Nelson Valerie   Altman Jessica K   Platanias Leonidas C  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 715-722

Informa Healthcare

Access to resources Recommend Favorite

Current and future directions in mammalian target of rapamycin inhibitors development

By Fasolo Angelica   Sessa Cristiana  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 381-394

Informa Healthcare

Access to resources Recommend Favorite

New inhibitors of the mammalian target of rapamycin signaling pathway for cancer

By Albert Sébastien   Serova Maria   Dreyer Chantal   Sablin Marie-Paule   Faivre Sandrine   Raymond Eric  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 919-930

Informa Healthcare

Access to resources Recommend Favorite

Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside

By Vincenzi Bruno   Napolitano Andrea   D'Onofrio Loretta   Frezza Anna Maria   Silletta Marianna   Venditti Olga   Santini Daniele   Tonini Giuseppe  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1685-1705

Informa Healthcare

Access to resources Recommend Favorite

Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents

By  

Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. : 621-635

Bentham Science Publishers

Access to resources Recommend Favorite